LY3185643

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3185643, covering 2019-03-13 to 2019-09-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3185643 and rGlucagon in Healthy Participants [Phase 1]